Biological Psychiatry
Volume 62, Issue 11 , Pages 1208-1216 , 1 December 2007

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

  • John P. O’Reardon

      Affiliations

    • Department of Psychiatry, University of Pennsylvania, Philadelphia
    • Corresponding Author InformationAddress reprint requests to John P. O’Reardon, M.D., Laboratory for Transcranial Magnetic Stimulation, University of Pennsylvania, 3535 Market Street, Suite 4005, Philadelphia, PA 19014.
    • ,
  • H. Brent Solvason

      Affiliations

    • Department of Psychiatry, Stanford University, Palo Alto, California
    • ,
  • Philip G. Janicak

      Affiliations

    • Department of Psychiatry, Rush University Medical Center, Chicago, Illinois
    • ,
  • Shirlene Sampson

      Affiliations

    • Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Keith E. Isenberg

      Affiliations

    • Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • Ziad Nahas

      Affiliations

    • Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • William M. McDonald

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia
    • ,
  • David Avery

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington
    • ,
  • Paul B. Fitzgerald

      Affiliations

    • Alfred Psychiatry Research Centre, the Alfred and Monash University School of Psychology, Psychiatry and Psychological Medicine, Melbourne, Australia
    • ,
  • Colleen Loo

      Affiliations

    • School of Psychiatry, University of NSW, Sydney, Australia
    • ,
  • Mark A. Demitrack

      Affiliations

    • Neuronetics, Inc., Malvern, Pennsylvania
    • ,
  • Mark S. George

      Affiliations

    • Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Harold A. Sackeim

      Affiliations

    • Department of Biological Psychiatry, New York State Psychiatric Institute and College of Physicians and Surgeons, Columbia University, New York.

Received 29 September 2006 ,Revised 25 November 2006 ,Accepted 19 January 2007.

References 

  1. Amassian VE, Eberle L, Maccabee PJ, Cracco RQ. Modelling magnetic coil excitation of human cerebral cortex with a peripheral nerve immersed in a brain-shaped volume conductor: The significance of fiber bending in excitation. Electroencephalo Clin Neuro. 1992;85:291–301
  2. Anderson B, Mishory A, Nahas Z, Borckardt JJ, Yamanaka K, Rastogi K, et al. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT. 2006;22:49–53
  3. Avery DH, Holtzheimer PE, Fawaz W, Russo J, Neumaier J, Dunner DL, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant depression. Biol Psychiatry. 2005;September 1 [Epub ahead of publication]
  4. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med. 1995;25:247–261
  5. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. The anatomy of melancholia—focal abnormalities of cerebral blood flow in major depression. Psychol Med. 1992;22:607–615
  6. Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings [see comment]. Arch Gen Psychiatry. 2001;58:631–640
  7. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: A meta analysis. Int J Neuropsychopharmacol. 2002;5:73–103
  8. Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: A systematic review and meta-analysis [see comment]. J Psychiatry Neurosci. 2005;30:83–90
  9. Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, et al. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: A STAR*D report. Am J Psychiatry. 2006;163:1161–1172
  10. Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: A double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2003;60:1002–1008
  11. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry. 1995;152:341–351
  12. George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J Clin Psychiatry. 1993;54:6–13
  13. George MS, Ketter TA, Post RM. SPECT and PET imaging in mood disorders. J Clin Psychiatry. 1993;54(suppl):6–13
  14. George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, et al. A controlled trial of daily left prefrontal cortex TMS for treating depression [see comment]. Biol Psychiatry. 2000;48:962–970
  15. George MS, Wassermann EM. Rapid-rate transcranial magnetic stimulation and ECT. Convuls Ther. 1994;10:251–254discussion 255–258
  16. George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: A placebo-controlled crossover trial. Am J Psychiatry. 1997;154:1752–1756
  17. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995;6:1853–1856
  18. Greden JF. The burden of recurrent depression: Causes, consequences, and future prospects. J Clin Psychiatry. 2001;22:5–9
  19. Herwig U, Satrapi P, Schonfeldt-Lecuona C. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 2003;16:95–99
  20. Herwig U, Schonfeldt-Lecuona C, Wunderlich AP, von Tiesenhausen C, Thielscher A, Walter H, et al. The navigation of transcranial magnetic stimulation. Psychiatry Res. 2001;108:123–131
  21. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database [see comment]. Arch Gene Psychiatry. 2000;57:311–317
  22. Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry. 2002;51:237–252
  23. Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: A double-blind controlled study [see comment]. Arch Gen Psychiatry. 1999;56:315–320
  24. Kozel A, George M. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract. 2002;8:270–275
  25. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry. 2006;59:990–996
  26. Loo C, Mitchell P, Sachdev P, McDarmont B, Parker G, Gandevia S. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry. 1999;156:946–948
  27. Loo C, Sachdev P, Elsayed H, McDarmot B, Mitchell P, Wilkonson M, et al. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients. Biol Psychiatry. 2001;49:615–623
  28. Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kulisevsky J, et al. Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews. 2002;2:CD003493
  29. Mayberg HS. Modulating limbic-cortical circuits in depression: Targets of antidepressant treatments. Sem Clin Neuropsychiatry. 2002;7:255–268
  30. Mayberg HS. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimag Clin North Am. 2003;13:805–815
  31. McNamara B, Ray JL, Arthurs OJ, Boniface S. Transcranial magnetic stimulation for depression and other psychiatric disorders [see comment]. Psychol Med. 2001;31:1141–1146
  32. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harcourt University Press; 1996;
  33. Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ECT. Am J Psychiatry. 2001;158:305–308
  34. Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression [see comment]. Lancet. 1996;348:233–237
  35. Pridmore S, Fernandes Filho JA, Nahas Z, Liberatos C, George MS. Motor threshold in transcranial magnetic stimulation: A comparison of a neurophysiological method and a visualization of movement method. J ECT. 1998;14:25–27
  36. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, et al. Resistance to antidepressant medications and short-term clinical response to ECT [see comment]. Am J Psychiatry. 1996;153:985–992
  37. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990;31:287–296
  38. Robinson RG, Boston JD, Starkstein SE, Price TR. Comparison of mania and depression after brain injury: Causal factors. Am J Psychiatry. 1988;145:172–178
  39. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: Importance of location of lesion. Brain. 1984;107:81–93
  40. Roth BJ, Cohen LG, Hallett M. the electric field induced during magnetic stimulation. In:  Lecy WJ,  Cracco RQ,  Barker AT,  Rothwell J editor. Magnetic Motor Stimulation: Basic Principles and Clinical Experience. Amsterdam: Elsevier Science; 1991;p. 268–278(EEG Suppl. 43)
  41. Roth BJ, Saypol JM, Hallett M, Cohen LG. A theoretical calculation of the electric field induced in the cortex during magnetic stimulation. Electroencephalo Clin Neuro. 1991;81:47–56
  42. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New Engl J Med. 2006;354:1231–1242
  43. Sackeim HA. Functional brain circuits in major depression and remission [comment]. Arch Gen Psychiatry. 2001;58:649–650
  44. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;16:10–17
  45. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10:96–104
  46. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713–728
  47. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry. 2005;66:974–981
  48. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry. 2006;163:28–40
  49. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108:1–16

PII: S0006-3223(07)00146-1

doi: 10.1016/j.biopsych.2007.01.018

Biological Psychiatry
Volume 62, Issue 11 , Pages 1208-1216 , 1 December 2007

Article Tools

* Image Usage & Resolution